Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? - PubMed
- ️Invalid Date
Review
. 2010 Nov-Dec;16(6):617-30.
doi: 10.1093/humupd/dmq010. Epub 2010 May 12.
Affiliations
- PMID: 20462941
- DOI: 10.1093/humupd/dmq010
Review
Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed?
Pascale Jadoul et al. Hum Reprod Update. 2010 Nov-Dec.
Abstract
Background: In prepubertal and adolescent girls, fertility may be impaired by gonadotoxic treatments, repeat ovarian surgery or genetic disorders. Cryopreservation of ovarian cortex is an existing option to preserve fertility in these young girls at risk of premature ovarian failure (POF). The efficacy, feasibility and risks of ovarian cryopreservation in children must be assessed in order to validate the technique.
Methods: Here, we conducted a review of ovarian cryopreservation in adults and, more specifically, in children using the PubMed databases. In addition, our own experience with ovarian cryopreservation in children was evaluated and compared with the literature.
Results: Analysis of the literature and six published series on ovarian cryopreservation in children, as well as our own series of 58 cases, show that there is no reason to doubt its efficacy in this young population. However, no consensus has yet been reached on the indications for the technique. Indeed, with existing models, the real risk of POF may be over- or underestimated.
Conclusion: Our review suggests that ovarian cortex cryopreservation is feasible and as safe as comparable operative procedures in children. Although no births have yet resulted from freeze-thawing of prepubertal ovarian cortex, the results of this approach in adults are encouraging. However, the absence of consensus on the indications for fertility preservation, as well as the optimal timing and quantity of ovarian cortex for cryopreservation, should be taken into consideration when discussing fertility issues with girls at risk of POF and their parents.
Comment in
-
Fertility preservation for girls and young women with cancer: what are the remaining challenges?
Wallace WH, Barr RD. Wallace WH, et al. Hum Reprod Update. 2010 Nov-Dec;16(6):614-6. doi: 10.1093/humupd/dmq038. Epub 2010 Aug 16. Hum Reprod Update. 2010. PMID: 20713417 No abstract available.
Similar articles
-
Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, Dechene J, Ferster A, Veys I, Fastrez M, Englert Y, Demeestere I. Imbert R, et al. Hum Reprod. 2014 Sep;29(9):1931-40. doi: 10.1093/humrep/deu158. Epub 2014 Jun 22. Hum Reprod. 2014. PMID: 24958067
-
[Fertility preservation in prepubertal children].
Poirot C, Schubert B. Poirot C, et al. Bull Cancer. 2011 May;98(5):489-99. doi: 10.1684/bdc.2011.1362. Bull Cancer. 2011. PMID: 21609893 Review. French.
-
Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer.
Poirot CJ, Martelli H, Genestie C, Golmard JL, Valteau-Couanet D, Helardot P, Pacquement H, Sauvat F, Tabone MD, Philippe-Chomette P, Esperou H, Baruchel A, Brugieres L. Poirot CJ, et al. Pediatr Blood Cancer. 2007 Jul;49(1):74-8. doi: 10.1002/pbc.21027. Pediatr Blood Cancer. 2007. PMID: 16977608
-
Moffa F, Biacchiardi CP, Fagioli F, Biasin E, Revelli A, Massobrio M, Madon E. Moffa F, et al. Pediatr Hematol Oncol. 2007 Jan-Feb;24(1):29-44. doi: 10.1080/08880010600970468. Pediatr Hematol Oncol. 2007. PMID: 17130112
-
Assisted reproduction and fertility preservation techniques in cancer patients.
Sönmezer M, Oktay K. Sönmezer M, et al. Curr Opin Endocrinol Diabetes Obes. 2008 Dec;15(6):514-22. doi: 10.1097/MED.0b013e32831a46fc. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18971680 Review.
Cited by
-
Fertility-Sparing Methods in Adolescents Affected by Endometrial Cancer: A Comprehensive Review.
Gałczyński K, Olcha P, Romanek-Piva K, Jóźwik M, Semczuk A. Gałczyński K, et al. J Clin Med. 2021 Mar 2;10(5):1020. doi: 10.3390/jcm10051020. J Clin Med. 2021. PMID: 33801452 Free PMC article. Review.
-
Effect of Previous Chemotherapy on the Quality of Cryopreserved Human Ovarian Tissue In Vitro.
Asadi Azarbaijani B, Sheikhi M, Oskam IC, Nurmio M, Laine T, Tinkanen H, Mäkinen S, Tanbo TG, Hovatta O, Jahnukainen K. Asadi Azarbaijani B, et al. PLoS One. 2015 Jul 30;10(7):e0133985. doi: 10.1371/journal.pone.0133985. eCollection 2015. PLoS One. 2015. PMID: 26226487 Free PMC article.
-
A predictive model of the effect of therapeutic radiation on the human ovary.
Kelsey TW, Hua CH, Wyatt A, Indelicato D, Wallace WH. Kelsey TW, et al. PLoS One. 2022 Nov 18;17(11):e0277052. doi: 10.1371/journal.pone.0277052. eCollection 2022. PLoS One. 2022. PMID: 36399448 Free PMC article.
-
Lotz L, Liebenthron J, Nichols-Burns SM, Montag M, Hoffmann I, Beckmann MW, van der Ven H, Töpfer D, Dittrich R. Lotz L, et al. Reprod Biol Endocrinol. 2014 May 15;12:41. doi: 10.1186/1477-7827-12-41. Reprod Biol Endocrinol. 2014. PMID: 24886634 Free PMC article.
-
Efficacy of ovarian tissue cryopreservation in a major European center.
Bastings L, Liebenthron J, Westphal JR, Beerendonk CC, van der Ven H, Meinecke B, Montag M, Braat DD, Peek R. Bastings L, et al. J Assist Reprod Genet. 2014 Aug;31(8):1003-12. doi: 10.1007/s10815-014-0239-7. Epub 2014 Jun 14. J Assist Reprod Genet. 2014. PMID: 24928054 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical